RxDoctor Payments Data

Krista Longmore

Family · Bradenton, FLNPI 1710603527

Payments from drug & device makers

$689in general payments, 2019–2025

Across 34 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$139
  • AbbVie$89
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$87
  • Novo Nordisk$58
  • Indivior Inc.$45
  • Lilly USA, LLC$39
  • plus $232 from 11 others

What the payments were for

  • Food & beverage$689100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$689 in reported general payments places this provider in the 60th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$159,628
Medicare patients
151
Services billed
1,695

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole25$15,768
EliquisApixaban11$3,667
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$330
Tramadol Hcl15$303
Ondansetron Hcl17$277
Ciprofloxacin Hcl27$276
Novolin R FlexpenInsulin Regular, Human11$232
Atorvastatin Calcium17$216
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$203
Gabapentin12$200
Lisinopril19$185
Levothyroxine Sodium13$184
Azithromycin12$178
Furosemide12$126
Metformin Hcl12$99

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$25$15,76825 claims
PfizerEliquis$20$3,66711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 14,618 family providers in Florida.

Other family in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →